The conference aims to serve as a premier platform for industry leaders, academicians, researchers, and regulatory experts to discuss advancements in pharmaceutical research, drug development, and industry-academia collaboration. Given India’s crucial role in global healthcare, the event is expected to provide key insights into strengthening research and development (R&D) capabilities while maintaining affordability in the pharma sector.

Key highlights of the conference include keynote addresses by national and international pharma experts, panel discussions on emerging collaborations, scientific presentations, poster sessions, exhibitions, specialized workshops, and networking opportunities.

Eminent personalities such as Dr. Montukumar M. Patel, President of PCI, and Mr. Namit Joshi, Chairman of Pharmexcil (Ministry of Commerce & Industry, Government of India), will be the chief guests. Other distinguished speakers include Dr. Deependra Singh, Chairman-PERC, Central Council PCI members Dr. M. Niranjan Babu and Dr. Akash Ved.

Renowned experts from the pharmaceutical industry and academia will deliver keynote speeches, including:

Dr. Ravindra Vikram Singh, Director & Head-R&D, Merck India,

Dr. Kailash C. Petkar, Senior Scientist, DSIR, Ministry of Science & Technology,

Dr. Arun Kumar Pandey, Senior VP-R&D, Alkem Laboratories Ltd.,

Dr. Aljosa Bolje, Expert (AS & T), Novartis, Slovenia,

Dr. Pranab K. Patra, Head-R&D, ADAMA,

Ms. Medha Pratap, Senior Director-Clinical Network, EME Morley, UK,

Dr. Ravindra Rawal, Principal Scientist (CS&T Division), CSIR-NEIST, Assam,

Dr. Chew Yik Ling, Associate Professor, UCSI University, Malaysia,

Prof. (Dr.) D Subhakar, Vice Chancellor of Amity University Bengaluru, emphasized that the conference would provide a unique platform for delegates to network, exchange groundbreaking insights, and foster innovation through strategic industry-academia collaborations.

Dr. P.S. Sali, Vice President-Academics, highlighted India’s role in meeting global healthcare demands through pharmaceutical production, stating that the conference would be highly relevant in addressing challenges and opportunities in the sector.

Prof. (Dr.) Amit Verma, Director-Research (i/c) and Organizing Secretary of the conference, announced that delegates would have the opportunity to participate in a specialized workshop on computational chemistry and molecular modeling. He also revealed that over 250 research papers have been received, and the conference is expected to attract more than 500 delegates from India and across the globe.

The event is anticipated to drive discussions on the future of pharmaceutical innovations and regulatory advancements, strengthening India’s position as a global leader in the pharma industry.